BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
17 results:

  • 1. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
    Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
    Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
    Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of postpartum breast cancer.
    Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
    Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
    Sandilos G; Lou J; Butchy MV; Gaughan JP; Reid L; Spitz FR; Beninato T; Moore MD
    Am J Surg; 2023 Jul; 226(1):53-58. PubMed ID: 36775791
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Correlation of conventional ultrasound features and related factors with BRAFV600E gene mutation in papillary thyroid carcinoma].
    Lv Y; He X; Yang F; Guo L; Qi M; Zhang J; Wang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 35(10):925-929. PubMed ID: 34628817
    [No Abstract]    [Full Text] [Related]  

  • 6. Hodgkin lymphoma involving extranodal sites in head and neck: report of twenty-nine cases and review of three-hundred and fifty-seven cases.
    Akhtar S; Khafaga Y; Edesa W; Al-Mubarak M; Rauf MS; Maghfoor I
    Hematology; 2021 Dec; 26(1):103-110. PubMed ID: 33478377
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Association of Histologically Proven Chronic Lymphocytic thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated thyroid cancer.
    Aydoğan Bİ; Mutlu ABB; Yüksel S; Güllü S; Emral R; Demir Ö; Şahin M; Gedik VT; Çorapçıoğlu D; Sak SD; Erdoğan MF
    Endocr Pathol; 2021 Jun; 32(2):280-287. PubMed ID: 33188468
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dissecting Anaplastic thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Xu B; Fuchs T; Dogan S; Landa I; Katabi N; Fagin JA; Tuttle RM; Sherman E; Gill AJ; Ghossein R
    Thyroid; 2020 Oct; 30(10):1505-1517. PubMed ID: 32284020
    [No Abstract]    [Full Text] [Related]  

  • 9. Common genetic variations of deiodinase genes and prognosis of brain tumor patients.
    Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R
    Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Association between body mass index and aggressiveness of papillary thyroid carcinoma].
    Faure EN; Soutelo MJ; Fritz MC; Martín A; Musri Y; Lutfi R
    Medicina (B Aires); 2018; 78(3):145-150. PubMed ID: 29940539
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma.
    Hara K; Saito T; Hayashi T; Mitani K; Takamochi K; Oh S; Suzuki K; Yao T
    Virchows Arch; 2017 Sep; 471(3):375-382. PubMed ID: 28725929
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Papillary thyroid carcinoma: different clinical behavior among pT3 tumors.
    Santos MJ; Bugalho MJ
    Endocrine; 2016 Sep; 53(3):754-60. PubMed ID: 27000081
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
    Zhao T; Liang J; Guo Z; Li J; Lin Y
    Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Our experience with papillary microcarcinoma of the thyroid].
    Garrel R; Cartier C; Marvaso V; Corpelet D; Makeieff M; Crampette L; Guerrier B
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(4):239-42. PubMed ID: 12723489
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extent of surgery for intermediate-risk well-differentiated thyroid cancer.
    Beenken S; Roye D; Weiss H; Sellers M; Urist M; Diethelm A; Goepfert H
    Am J Surg; 2000 Jan; 179(1):51-6. PubMed ID: 10737579
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Mass screening for breast cancer in Gunma prefecture--the results for 8 years and future problems].
    Ishida T; Yokoe T; Ogawa T; Kurosumi M; Kurebayashi J; Yoshida M; Yamada I; Iino Y; Izuo M
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2400-10. PubMed ID: 2614178
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.